About Vectura

We are a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients.

Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed

News

Pre-close trading update confirms 2020 trading ahead of expectations

12/01/2021

Today we announce an unaudited 2020 pre-close trading update. The Group expects revenue and Adjusted EBITDA for 2020 to be...

Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors

30/12/2020

Vectura Group plc (LSE: VEC) (“Vectura”, the “Group”, or the “Company”), an industry-leading specialist inhalation CDMO, is pleased to announce...

Environmental, Social and Governance (ESG) Strategy

Know more about our commitment to creating long-term growth by embedding sustainability in all our business practices.

DOWNLOAD ESG REPORT